Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation

Am J Crit Care. 1998 Sep;7(5):364-9.

Abstract

Background: Complications of opioid analgesia include tolerance and withdrawal.

Objectives: To determine the effects of morphine and fentanyl on the prevalence of withdrawal after extracorporeal membrane oxygenation.

Methods: Two groups of neonates were compared during and after extracorporeal membrane oxygenation: a prospective group receiving a continuous infusion of morphine for analgesia and sedation and a retrospective group who had received a continuous infusion of fentanyl.

Results: Neonates receiving morphine required significantly less supplemental analgesia (P < .001) than did neonates who had received fentanyl and had a significantly lower prevalence of withdrawal after the therapy (P = .01). Neonates receiving morphine were discharged from the hospital a mean of 9.6 days sooner (P = .01) than neonates who had received fentanyl.

Conclusions: Morphine may offer marked advantages over fentanyl for providing continuous analgesia and sedation in neonates.

Publication types

  • Comparative Study

MeSH terms

  • Analgesics, Opioid / adverse effects*
  • Extracorporeal Membrane Oxygenation*
  • Fentanyl / adverse effects*
  • Humans
  • Infant, Newborn
  • Infusions, Intravenous
  • Morphine / adverse effects*
  • Nursing Assessment
  • Nursing Records
  • Patient Care Planning
  • Prevalence
  • Prospective Studies
  • Retrospective Studies
  • Substance Withdrawal Syndrome / etiology*
  • Substance Withdrawal Syndrome / nursing

Substances

  • Analgesics, Opioid
  • Morphine
  • Fentanyl